Top Key Companies for Weight-loss Drugs Market: Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd, Swiss Research Labs Ltd., Roar Ambition, Health and Nutrition Ltd., Abbott, Kellogg Company, Glanbia PLC, Ajinomoto Co. Inc., Kraft Heinz Company, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., PepsiCo, Nestle, Amway Corp..
Global Weight-loss Drugs Market Research Report: 2023-2030 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global Weight-loss Drugs Market Overview And Scope:
The Global Weight-loss Drugs Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Weight-loss Drugs utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Weight-loss Drugs Market Segmentation
By Type, Weight-loss Drugs market has been segmented into:
Liquid
Powder
Softgels
Pills
Others
By Application, Weight-loss Drugs market has been segmented into:
Online Sales
Hospitals and Clinics
Pharmacy
Others
Regional Analysis of Weight-loss Drugs Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Weight-loss Drugs Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Weight-loss Drugs market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Weight-loss Drugs market.
Top Key Companies Covered in Weight-loss Drugs market are:
Novo Nordisk
Currax
Ultimate life ltd
Wolfson Berg Ltd
Swiss Research Labs Ltd.
Roar Ambition
Health and Nutrition Ltd.
Abbott
Kellogg Company
Glanbia PLC
Ajinomoto Co. Inc.
Kraft Heinz Company
GlaxoSmithKline PLC
Herbalife Nutrition Ltd.
PepsiCo
Nestle
Amway Corp.
Key Questions answered in the Weight-loss Drugs Market Report:
1. What is the expected Weight-loss Drugs Market size during the forecast period, 2022-2028?
2. Which region is the largest market for the Weight-loss Drugs Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Weight-loss Drugs Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Weight-loss Drugs Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Weight-loss Drugs companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Weight-loss Drugs Markets?
7. How is the funding and investment landscape in the Weight-loss Drugs Market?
8. Which are the leading consortiums and associations in the Weight-loss Drugs Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Weight-loss Drugs Market by Type
5.1 Weight-loss Drugs Market Overview Snapshot and Growth Engine
5.2 Weight-loss Drugs Market Overview
5.3 Liquid
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Liquid: Geographic Segmentation
5.4 Powder
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Powder: Geographic Segmentation
5.5 Softgels
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Softgels: Geographic Segmentation
5.6 Pills
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Pills: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2030F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
Chapter 6: Weight-loss Drugs Market by Application
6.1 Weight-loss Drugs Market Overview Snapshot and Growth Engine
6.2 Weight-loss Drugs Market Overview
6.3 Online Sales
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Online Sales: Geographic Segmentation
6.4 Hospitals and Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Hospitals and Clinics: Geographic Segmentation
6.5 Pharmacy
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Pharmacy: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Weight-loss Drugs Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Weight-loss Drugs Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Weight-loss Drugs Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 NOVO NORDISK
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CURRAX
7.4 ULTIMATE LIFE LTD
7.5 WOLFSON BERG LTD
7.6 SWISS RESEARCH LABS LTD.
7.7 ROAR AMBITION
7.8 HEALTH AND NUTRITION LTD.
7.9 ABBOTT
7.10 KELLOGG COMPANY
7.11 GLANBIA PLC
7.12 AJINOMOTO CO. INC.
7.13 KRAFT HEINZ COMPANY
7.14 GLAXOSMITHKLINE PLC
7.15 HERBALIFE NUTRITION LTD.
7.16 PEPSICO
7.17 NESTLE
7.18 AMWAY CORP.
Chapter 8: Global Weight-loss Drugs Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Liquid
8.2.2 Powder
8.2.3 Softgels
8.2.4 Pills
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Online Sales
8.3.2 Hospitals and Clinics
8.3.3 Pharmacy
8.3.4 Others
Chapter 9: North America Weight-loss Drugs Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Liquid
9.4.2 Powder
9.4.3 Softgels
9.4.4 Pills
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Online Sales
9.5.2 Hospitals and Clinics
9.5.3 Pharmacy
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Weight-loss Drugs Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Liquid
10.4.2 Powder
10.4.3 Softgels
10.4.4 Pills
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Online Sales
10.5.2 Hospitals and Clinics
10.5.3 Pharmacy
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Weight-loss Drugs Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Liquid
11.4.2 Powder
11.4.3 Softgels
11.4.4 Pills
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Online Sales
11.5.2 Hospitals and Clinics
11.5.3 Pharmacy
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Weight-loss Drugs Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Liquid
12.4.2 Powder
12.4.3 Softgels
12.4.4 Pills
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Online Sales
12.5.2 Hospitals and Clinics
12.5.3 Pharmacy
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Weight-loss Drugs Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Liquid
13.4.2 Powder
13.4.3 Softgels
13.4.4 Pills
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Online Sales
13.5.2 Hospitals and Clinics
13.5.3 Pharmacy
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Weight-loss Drugs Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Liquid
14.4.2 Powder
14.4.3 Softgels
14.4.4 Pills
14.4.5 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Online Sales
14.5.2 Hospitals and Clinics
14.5.3 Pharmacy
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Weight-loss Drugs Scope:
Report Data
|
Weight-loss Drugs Market
|
Weight-loss Drugs Market Size in 2022
|
USD XXX million
|
Weight-loss Drugs CAGR 2023 - 2030
|
XX%
|
Weight-loss Drugs Base Year
|
2022
|
Weight-loss Drugs Forecast Data
|
2023 - 2030
|
Segments Covered
|
By Type, By Application, And by Regions
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
Key Companies Profiled
|
Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd, Swiss Research Labs Ltd., Roar Ambition, Health and Nutrition Ltd., Abbott, Kellogg Company, Glanbia PLC, Ajinomoto Co. Inc., Kraft Heinz Company, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., PepsiCo, Nestle, Amway Corp..
|
Key Segments
|
By Type
Liquid Powder Softgels Pills Others
By Applications
Online Sales Hospitals and Clinics Pharmacy Others
|
Research Methodology